Global Classical Swine Fever Vaccines Market Size Likely to Grow At a CAGR of 8.3% By 2035

The global market for classical swine fever vaccines is estimated at USD 1.24 billion in 2025 and is projected to increase from USD 1.34 billion in 2026 to an approximate USD 2.87 billion by 2035 with 8.3% CAGR from 2026 to 2035.

Classical Swine Fever Vaccines Market Revenue and Trends

Classical Swine Fever vaccines are veterinary products used to prevent the highly contagious Classical Swine Fever virus (CSFV) and are offered on the global market. These include live attenuated vaccines, inactivated vaccines and marker (DIVA) vaccines for routine immunization, emergency outbreak control and eradication programs for domestic swine herds. The classical swine fever vaccines market is expanding at a steady pace across the globe due to the growing production of pork, constant threat of the disease in endemic regions, growing adoption of preventive animal health measures, government regulations and campaigns to vaccinate pigs, and improvements in vaccine technology for classical swine fever (P.S. F. Vx) across the world.

What are the Factors That Have a Significant Contribution to the Growth of the classical swine fever vaccines market?

The rising need for effective vaccines to prevent and protect pig herds is the result of the growth of commercial pig production, the threat of trade restrictions as classical swine fever spread and the significant losses from this disease. Consistent use in national control and eradication programmes in the main pig-producing countries benefit the market, industry reports. With increasing intensive swine production and heightened biosecurity awareness, farmers, vets, and governments are looking to vaccines that are both effective and reliable to complement modern farm management practices and to ensure long-term food security and animal health.

Technological advances have enabled the development of marker vaccines for DIVA strategies, thermostable vaccines and combination vaccines with more comprehensive coverage, thus enhancing the safety, efficacy and field-friendliness of vaccines. Other drivers are increased emphasis on livestock disease control and trade compliance; better access to quality vaccines in developing markets; government efforts and investment in animal husbandry and veterinary health programs, both developed and developing.

Segment Insight

By Product Type

As of 2025, the highest market share is occupied by live attenuated classical swine fever vaccines, which are known for being very immunogenic, maintaining immunity for a longer period, cost effective and widely used in national vaccine campaigns on a large scale. These vaccines are vital to commercial pig producers and veterinary authorities looking to successful outbreak prevention and control, and have seen significant growth in the development of safer attenuated strains as well as differentiating marker vaccines – a product which veterinarians and swine health authorities consider critical to successful outbreak prevention and control efforts in endemic and at-risk areas.

By Distribution Channel

Veterinary hospitals have the highest percentage followed by government procurement and animal health distributors, which are the main channels for bulk supply, cold-chain transportation, veterinary advice and mass vaccination campaigns. The channels offer a more expert dosing advice and compliance with requirements for regulations as well as reliable distribution for big farms, cooperatives and veterinary departments which carry out routine or emergency vaccination campaigns, and are the best choice for organisations working on critical livestock health campaigns.

Regional Insights

The Asia Pacific classical swine fever vaccines market is growing at a significant rate, as the area is home to a large number of pigs, particularly in China and Southeast Asia, where the disease is endemic, and has high vaccination coverage rates with strong government initiatives along with higher commercial pork production in the area. This area has significant investment in public animal health and large scale farms, with strong demand for preventive vaccines, and resulting in continuous market stability.

The Asia Pacific region is also showing the highest growth in classical swine fever vaccines market, as a result of the rising pork consumption, growing intensive farming systems, strengthening veterinary care infrastructure and favorable government policies for disease control. Focusing on swine productivity and the awareness of economic losses due to outbreaks, countries such as China, Vietnam, India and the Philippines are seeing uptake of advanced and marker vaccines, with local manufacturing capabilities. The market is further set to expand in Asia Pacific due to the growth of pig farming and the increasing biosecurity measures involved in trading pigs.

Report Scope

Recent Developments

• In 2025: Boehringer Ingelheim has released a new marker vaccine for classical swine fever (CSF) that is more DIVA compatible and safer, further bolstering disease control programs and ensuring compliance with export requirements for swine producers in major Asian markets.

List of the prominent players in the Classical Swine Fever Vaccines Market:

• Boehringer Ingelheim Animal Health

• Merial (Zoetis Subsidiary)

• Ceva Santé Animale

• Novacor Biotech

• Agrovet Animal Health

• CAHIC (China Animal Husbandry Industry Co. Ltd.)

• Hipra (Laboratorios Hipra S.A.)

• Intervet-Schering Plough

• Vacsera

• Indian Immunologicals Limited

OthersThe Classical Swine Fever Vaccines Market is segmented as follows:

By Vaccine Type

• Inactivated Vaccines

  • Oil-Adjuvanted Inactivated Vaccines

  • Aluminum Hydroxide Adjuvanted Vaccines

  • Emulsion-Based Inactivated Vaccines

• Attenuated Live Vaccines

  • Classical Lapinized Vaccines

  • Cell Culture-Adapted Vaccines

  • Tissue Culture Vaccines

• Chimeric Vaccines

  • E2 Deletion Vaccines

  • NS3-4A Deletion Vaccines

  • Other Chimeric Formulations

• Other Vaccine Types

  • Recombinant Vaccines

  • Subunit Vaccines

By Delivery Method

• Intramuscular Injections

• Oral Vaccines

• Intranasal Vaccines

• Other Delivery Methods

By Animal Type

• Domestic Swine

  • Piglets

  • Growing/Finishing Pigs

  • Breeding Stock

• Wild Boar

• Other Species

By End User

• Livestock Farms

  • Industrial Farms

  • Small-Scale Farms

• Animal Health Clinics

• Veterinary Hospitals

• Other Facilities

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America